Preimplantation genetic diagnosisis used for a broader range of indications, including chromosomalabnormalities, genetic abnormalities associated with adult onset disorders,rhesus incompatibility, human leukocyte antigens (HLA) tissue type, andintentionally selecting for medical conditions (deafness) and traits like sex.
Statistics:
The global PreimplantationGenetic Diagnosis Market is estimated to account for US$ 53.5 Mn in termsof value in 2020 and is expected to reach US$ 81.6 Mn by the end of 2027.
Global Preimplantation GeneticDiagnosis Market: Drivers
Rising rate of infertility isexpected to propel growth of the global preimplantation genetic diagnosismarket over the forecast period. For instance, according to the National Surveyof Family Growth data published in September 2018, 15.5% of all women whointend to become pregnant are infertile and 6.7% of married women aged 15 to 44years are infertile, in the U.S.
Global Preimplantation Genetic DiagnosisMarket: Opportunities
R&D in genetics is expectedto offer lucrative growth opportunities for players in the globalpreimplantation genetic diagnosis market. People want to be guilt free fromgiving the sufferings of genetic disorders to their children. Clinical progressin the IVF and preimplantation genetic diagnosis and the increasing knowledgein the medicine and molecular field associated with both male and femaleinfertility and that in intracytoplasmic sperm injection will assist in growthof the global preimplantation genetic diagnosis market.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/698
Global Preimplantation GeneticDiagnosis Market: Restraints
Scientific, ethical, and policyissues are expected to hinder growth of the global preimplantation geneticdiagnosis market. There are quite a few issues persistent about the safety ofthe in vitro fertilization in preimplantation genetic diagnosis. The accuracyof these methods is also questioned by a few physicians and researchers. Inaddition, few people also find preimplantation genetic diagnosis as morallyunacceptable because of involvement of unnatural creation and destruction ofhuman embryo. There is a huge ethical issues regarding whether preimplantationgenetic diagnosis should be adopted or not.
Key Takeaways:
The global preimplantationgenetic diagnosis market was valued at US$ 50.3 Mn in 2019 and is forecast toreach a value of US$ 81.6 Mn by 2027 at a CAGR of 6.2% between 2020 and 2027.Major factor driving the growth of global preimplantation genetic diagnosismarket during the forecast period include increasing incidences of geneticdiseases, and increasing number of fertility centers.
Chromosomal Abnormalities helddominant position in the global preimplantation genetic diagnosis market in 2019,accounting for 20.1% share in terms of value, followed by X-linked diseases andAneuploidy, respectively. Increasing prevalence of genetic disorders is supportinggrowth of the segment.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/preimplantation-genetic-diagnosis-market-698
Market Trends
Major players in the globalpreimplantation genetic diagnosis market are focused on adopting partnershipand collaboration strategies to enhance their market share. For instance, inOctober 2018, Illumina Inc. signed an agreement with Vitrolife AB under whichVitrolife act as a distributor supplier of Illumina’s PGT products in EMEA andAmerica.
Major players in the globalpreimplantation genetic diagnosis market are also focused on adopting expansionstrategies to enhance their market share. For instance, in June 2020, Natera,Inc. announced the expansion of its laboratory facility in Austin, Texas,supporting greater test processing capacity.
Global Preimplantation GeneticDiagnosis Market: Competitive Landscape
Major players operating in theglobal preimplantation genetic diagnosis include, Amgen, Quest Diagnostics,Genentech Inc., Vertex, PerkinElmer, Inc., F. Hoffman-La-Roche Ltd, ThermoFisher Scientific, Inc., Laboratory Corporation of America Holdings, AbbottLaboratories, Illumina, Inc., Natera Inc., CooperGenomics Inc., ReproductiveGenetics Institute, Inc., Genea Ltd., Invitae Corporation, and CombiMatrixCorporation.
Global Preimplantation GeneticDiagnosis Market: Key Developments
Major players in the globalpreimplantation genetic diagnosis market are focused on adopting variousstrategies to enhance their market share. For instance, in April 2019, QuestDiagnostics presented new insights from genetic testing at the 2019 AmericanCollege of Medical Genetics and Genomics (ACMG) Annual Clinical GeneticsMeeting, held in the U.S.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/698
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-173
